New trends in antimicrobial therapy of chronic purulent mesotympanitis

Tsetsarskiĭ, B.M.; Mikhalashvili, A.E.; Makhlinovskaia, N.V.; Koshel', V.I.; Faians, A.A.; Semenova, F.S.

Vestnik Otorinolaringologii 2: 49-50

1999


ISSN/ISBN: 0042-4668
PMID: 10226495
Document Number: 506578
Antibiotic therapy with colbiocin of chronic purulent mesotympanitis achieved a response rate of 92%, recurrence-free interval reached 6 months in 84% of the treated patients. This allows to recommend colbiocin as a drug of choice in hospital and outpatient treatment of chronic purulent mesotympanitis.

Document emailed within 1 workday
Secure & encrypted payments